Ultragenyx
RARE
$44.24
Share price
0.89%
Change (1 day)
1.31%
Change (1 year)
Categories
EPS for Ultragenyx (RARE)
EPS in 2023 (TTM): -$10.24
According to Ultragenyx's latest financial reports the company's current EPS (TTM) is -$10.24. In 2022 the company made an earnings per share (EPS) of -$10.11 a decrease over its 2021 EPS that were of -$6.71.
EPS history for Ultragenyx from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$10.24 | 1.29% |
| 2022 | -$10.11 | 50.67% |
| 2021 | -$6.71 | 113.69% |
| 2020 | -$3.14 | -55.9% |
| 2019 | -$7.12 | 82.56% |
| 2018 | -$3.90 | -45.15% |
| 2017 | -$7.11 | 14.68% |
| 2016 | -$6.20 | 57.36% |
| 2015 | -$3.94 | 69.83% |
| 2014 | -$2.32 | 15.22% |
| 2013 | -$2.01 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | -$0.68 | -93.36% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$2.82 | -72.46% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.64 | -93.75% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -107.60% | 🇺🇸 USA |